SAB Biotherapeutics, Inc.

Q2 2024 13F Holders

Symbol
SABS
CUSIP
78397T202
Type
Equity
Class
COM NEW
Num filings
25
Total reported value, excl. options
$9.70 M
Manager Report Date Value ($000) Shares Option Type